InMode

Company Overview

Snapshot

Founded in January 2008 by Moshe Mizrahy, InMode operates with over 500 employees. The company has raised $70 million across one public funding round. In August 2019, InMode went public on NASDAQ.

Business overview

InMode is a global provider of energy-based aesthetic solutions, specializing in minimally invasive and noninvasive technologies. The company develops and commercializes products utilizing medically accepted radio-frequency (RF) energy technology, designed to penetrate deep into the subdermal fat layer for adipose tissue remodeling. Physicians use InMode's technologies for various procedures, including liposuction with simultaneous skin tightening, face and body contouring, and ablative skin rejuvenation treatments. Its product portfolio includes workstations like BodyTite and Optimas, serving the medical aesthetic and skincare markets.

Strategic signal

In September 2025, DOMA Perpetual sent a letter urging. This signal suggests a potential shift in the company's financial strategy towards shareholder returns, which could influence future investment decisions and market perception.

Company Intelligence Q&A

When did InMode go public?

InMode went public on NASDAQ in August 2019.

What was InMode's last disclosed funding amount?

InMode's last disclosed funding was $70 million, raised during its public offering.

What was InMode's market capitalization as of January 2026?

InMode's market capitalization was $928,542,443 as of January 2026.

Did InMode make any acquisitions recently?

In July 2023, InMode expanded its women's health and wellness market footprint through the acquisition of Viveve Medical's patents.

What was a key financial update from InMode in October 2025?

In October 2025, InMode announced it expected to report Q3 2025 revenue between $92.5 million and $93.0 million, reiterating its full-year 2025 guidance of $365 million to $375 million.